Isoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted Precision Oncology Medicine Feb 6, 2023 08:10AM
Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders Jan 30, 2023 08:10AM
Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023 Jan 12, 2023 04:05PM
AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023 Dec 14, 2022 05:08PM
Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2022 Dec 14, 2022 04:05PM
View Older Stories

Nov 10, 2022 04:05PM Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger
Oct 31, 2022 08:14AM Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022
Oct 18, 2022 04:30PM Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT
Sep 28, 2022 04:05PM Isoray Announces Transformational Merger and Fourth Quarter and Full-Year Fiscal Year End 2022 Financial Results
Sep 21, 2022 08:13AM Isoray To Announce Fourth Quarter and Fiscal Year End 2022 Financial Results on September 28, 2022
Jun 21, 2022 08:10AM Isoray’s Cesium-131 Featured in Presentations at American Brachytherapy Society’s Annual Conference
Jun 15, 2022 08:10AM Isoray To Host Lunch Symposium At American Brachytherapy Society’s Annual Conference
May 10, 2022 04:05PM Isoray Announces Record Third Quarter Fiscal 2022 Financial Results
Apr 29, 2022 08:05AM Isoray To Announce Third Quarter Fiscal 2022 Financial Results on May 10, 2022
Mar 10, 2022 08:13AM Isoray to Participate in the Oppenheimer 32nd Annual Healthcare Conference
Mar 2, 2022 08:17AM IsoRay (ISR) Reports Study Showing Excellent Outcomes for Intermediate Risk Prostate Cancer Patients Treated with Isoray’s Cesium-131
Mar 2, 2022 08:13AM Study Finds Excellent Outcomes for Intermediate Risk Prostate Cancer Patients Treated with Isoray’s Cesium-131
Feb 8, 2022 04:05PM Isoray Announces Second Quarter Fiscal 2022 Financial Results
Jan 26, 2022 08:10AM Isoray To Announce Second Quarter Fiscal 2022 Financial Results on February 8, 2022
Nov 10, 2021 04:05PM Isoray Announces First Quarter Fiscal 2022 Financial Results
Oct 29, 2021 08:13AM Isoray To Announce First Quarter Fiscal 2022 Financial Results on November 10, 2021
Sep 28, 2021 08:15AM IsoRay (ISR) Announces American Brachytherapy Society LDR Prostate Brachytherapy Treatment Consensus Paper Recognizes Cesium-131
Sep 28, 2021 08:13AM American Brachytherapy Society LDR Prostate Brachytherapy Treatment Consensus Paper Recognizes Isoray’s Cesium-131
Sep 21, 2021 06:59PM Isoray Reschedules Fourth Quarter and Fiscal Year End 2021 Financial Results Conference Call to September 22, 2021 Due to Conference Provider Technical Issues
Sep 21, 2021 04:05PM Isoray Announces Fourth Quarter and Full-Year Fiscal Year End 2021 Financial Results
Sep 9, 2021 08:13AM Isoray To Announce Fourth Quarter and Fiscal Year End 2021 Financial Results on September 21, 2021
May 13, 2021 04:05PM Isoray Announces Third Quarter Fiscal 2021 Financial Results
Apr 29, 2021 08:13AM Isoray To Announce Third Quarter Fiscal 2021 Financial Results on May 13, 2021
Apr 13, 2021 08:13AM Isoray Announces the Appointment of Donna Fort as Vice President Sales and Marketing
Mar 31, 2021 08:13AM University Hospitals Cleveland Medical Center Pilot Study Shows Promise for High-Risk Recurrent Head and Neck Cancer Treatment with Cesium-131 and Surgical Resection
Mar 3, 2021 08:13AM Isoray to Present at the Oppenheimer 31st Annual Healthcare Conference
Feb 16, 2021 08:13AM Isoray Announces the Appointment of Lisa Lauer As Vice President Business Development
Feb 9, 2021 04:06PM Isoray Announces Second Quarter Fiscal 2021 Financial Results
Feb 5, 2021 08:13AM Isoray To Announce Second Quarter Fiscal 2021 Financial Results on February 9, 2021
Feb 4, 2021 08:36AM IsoRay (ISR) Prices $45 Million Public Offering of Common Stock at $1.25/sh
Feb 4, 2021 08:30AM Isoray Announces Pricing of $45 Million Public Offering
Feb 3, 2021 04:01PM IsoRay (ISR) to Offer Common Stock
Feb 3, 2021 04:01PM Isoray Announces Proposed Underwritten Public Offering
Jan 7, 2021 08:13AM Isoray to Present at the H.C. Wainwright BioConnect 2021 Conference
Jan 5, 2021 05:08PM C4 Imaging Announces Sirius Positive Signal MRI Marker Given FDA 510(k) Clearance for Use with Isoray's (ISR) Cesium-131 Brachytherapy Seeds to Treat Prostate Cancer
Jan 5, 2021 04:55PM C4 Imaging Announces Sirius Positive Signal MRI Marker Given FDA 510(k) Clearance for Use with Isoray’s Cesium-131 Brachytherapy Seeds to Treat Prostate Cancer
Nov 24, 2020 08:13AM Isoray’s Cesium-131 Spotlighted in Multiple Presentations at ASTRO
Nov 10, 2020 04:05PM Isoray Announces First Quarter Fiscal 2021 Financial Results
Nov 2, 2020 08:13AM Isoray To Announce First Quarter Fiscal 2021 Financial Results on November 10, 2020
Oct 20, 2020 09:01AM IsoRay (ISR) Prices 9.135M Share & Warrants Offering at $0.52/Sh
Oct 20, 2020 09:00AM Isoray, Inc. Announces Pricing of $9.5 Million Public Offering
Oct 19, 2020 04:57PM IsoRay (ISR) Announces Proposed Underwritten Public Offering of Common Stock, Warrants
Oct 19, 2020 04:56PM Isoray, Inc. Announces Proposed Underwritten Public Offering
Sep 17, 2020 04:05PM Isoray Announces Fourth Quarter and Full-Year Fiscal Year End 2020 Financial Results
Sep 16, 2020 08:13AM Isoray to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Sep 10, 2020 08:13AM Isoray To Announce Fourth Quarter and Fiscal Year End 2020 Financial Results on September 17, 2020
Aug 18, 2020 08:00AM GT Medical Technologies Announces Data Demonstrating Positive Local Control and Safety Outcomes with GammaTile Therapy for Large Brain Metastases
Jun 17, 2020 08:13AM Isoray and University of Cincinnati Physicians Company Sign Research Agreement to Study Treatment of Head and Neck Cancers 
Jun 2, 2020 08:13AM Second Ten Year Data Report Demonstrates Efficacy of Isoray’s Cesium-131 Internal Radiation Therapy in the Treatment of Prostate Cancer
May 12, 2020 04:17PM Isoray Announces Record Third Quarter Fiscal 2020 Financial Results
View Older Stories